MBOAT7 and hepatocellular carcinoma: Conversely, increased MBOAT7 expression is correlated with detrimental outcomes in cancers, such as hepatocellular carcinoma and clear cell renal carcinomas29,30, suggesting that inhibitors of MBOAT7 may be useful therapeutic agents.